Anyone associated with ASCs is aware of the sweeping changes CMS has instituted to the facility payment system. Few specialties or procedures have undergone more changes than prostate brachytherapy.

Plasma Osteopontin Is an Independent Prognostic Marker for Head and Neck Cancers We analyzed claims for Medicare-enrolled men older than age 65 years living in Surveillance, Epidemiology, and End ...

When Beth Ann Meyer’s husband, Stewart, was diagnosed with prostate cancer last fall they considered their treatment options. The Chickasha couple chose the benefits of brachytherapy offered at ...

NEW YORK (Reuters Health) - Among men with good sexual function before treatment with low-dose brachytherapy for prostate cancer, erectile function is likely to remain good over the long term, ...

The impact of partial brachytherapy on metastasis and disease-specific mortality is unclear. Partial prostate treatment with MRI-guided brachytherapy may lead to poor outcomes long-term among patients ...

Brachytherapy-based regimens appear to be effective salvage treatment for localized radiorecurrent prostate cancer, investigators reported at the 2024 ASCO Genitourinary Cancers Symposium in San ...